Product Information
CLONAZEPAM 0.25 MG ODT is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.4744 per EA under NDC 00093929167. Its NADAC has been published 213 times since Jun 1, 2022.
Strength
.25 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093929167
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA077194On Market Since
3/2/2022
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 0.25 MG ODT has been published 213 times since Jun 1, 2022, and over the history we have for it it has declined 32.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4744 per EA |
|---|---|
| All-time high | $0.7486 (Aug 10, 2022) |
| All-time low | $0.3522 (Jan 17, 2024) |
| 52-week high | $0.6792 |
| 52-week low | $0.4331 |
| Median price | $0.5202 |
| Average price | $0.5343 |
| Largest weekly change | +52.3% (Feb 21, 2024) |
| Weeks tracked | 213 |
| Tracking since | Jun 1, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Clonazepam market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CLONAZEPAM 0.25 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 0.25 MG ODT, manufactured by Teva Pharmaceuticals USA Inc., is $0.4744 per EA (NDC 00093929167), effective Jun 24, 2026.
How has the price of CLONAZEPAM 0.25 MG ODT changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 0.25 MG ODT has declined 32.5%. It has been tracked across 213 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 0.25 MG ODT?
Since Jun 1, 2022, the NADAC for CLONAZEPAM 0.25 MG ODT has ranged from a low of $0.3522 (Jan 17, 2024) to a high of $0.7486 (Aug 10, 2022), with a median of $0.5202 per EA.
Are there cheaper alternatives to CLONAZEPAM 0.25 MG ODT?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CLONAZEPAM 0.25 MG ODT, so no direct lower-cost alternative is listed.
Who manufactures CLONAZEPAM 0.25 MG ODT?
CLONAZEPAM 0.25 MG ODT (NDC 00093929167) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification